About US
Contact us
-
FDA approval smooths way to more Botox salesWhile Botox still primarily springs to mind as a cosmetic treatment for wrinkles, the Allergan ($AGN) drug has been approved for 26 indications in 85 countries. The latest, and one it has been longin2013/1/23
-
Novo ready to rev up Tresiba for European launchNovo Nordisk ($NVO) is ready to roll with its new diabetes drug Tresiba--in Europe, at least. The company won regulatory approval for the potential blockbuster yesterday, setting up a mano-a-mano fig2013/1/23
-
Top pharmacists gather for conferenceA number of top independent pharmaceutical companies are set to gather for a conference this February in order to develop strategies that will enable progress in a radically changing health market.2013/1/22
-
BioChemics patents wound healing treatmentThe US Patent and Trademark office has issued a new patent for 'Methods and Compositions for Topical Treatment of Medical Conditions Including Wounds and Inflammation' on behalf of pharmaceutical firm2013/1/22
-
DSM Announces License Agreement with Amgen for Use of DSM's XD® Cell Culture PatentsDSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM (NYSE, Euronext: DSM KON), announced today that it has signed a non-exclusive license agreement with Amgen I2013/1/21
-
Pfizer's Bosulif set for greater sales with EMA approvalPfizer ($PFE) has extended the run of good news for its focus on targeted cancer treatment with a positive recommendation from EU regulators for Bosulif. The nod sets the stage for another approval a2013/1/21
-
Drugmakers beware, Costco now in pharmacy benefitsIn the evolving drug payer world, pharmacy benefit managers (PBM) are commanding a bigger role. Now drug companies have a new and interesting PBM with which to contend--Costco. The discounter has s2013/1/18
-
Additional testing completed on Alzheimer's disease biomarkerBiopharma company Navidea Biopharmaceuticals has announced the completion of a study into its new radiopharmaceutical NAV4694, which is designed to be used as a biomarker for visual detection of subs2013/1/18
-
EU signs off on Lilly's Amyvid, its diagnostic test for Alzheimer'sWhile Eli Lilly struggles with development of its therapy for treating Alzheimer's disease, its diagnostic imaging agent for helping diagnose, or rule out, the condition has gotten another approval, t2013/1/17
-
Armed with diagnostic, Biogen files for first-line Tysabri useIf persistence is a virtue, then Biogen Idec ($BIIB) is about as virtuous as they come. After years of safety problems, warnings, testing and retesting, the company has asked U.S. and European authori2013/1/17